Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95c51305b25e433ac11f598e22d58a14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
1989-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1996-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e2132084791df330a00cd8f4359ae2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d5d795aa8eb5652a2fd63aae4bdd1c |
publicationDate |
1996-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-1338737-C |
titleOfInvention |
Porphyrins and cancer treatment |
abstract |
This invention provides novel compounds for therapy of tumours susceptible to necrosis when an appropriate compound is administered followed by illumination with light of a wavelength absorbed by the compound, the compounds being dihydro porphyrins of the formula, or the corresponding tetra-hydro porphyrins: IV where n = 1 to 3 and each substituent R, the same or different and at the same or different position in its respective substituent phenyl ring, is an hydroxy group. |
priorityDate |
1988-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |